Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 2 von 25

Details

Autor(en) / Beteiligte
Titel
Toward the Discovery of Novel Anti-HIV Drugs. Second-Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti-HIV Activity: Synthesis, Structure-Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation
Ist Teil von
  • ChemMedChem, 2011-08, Vol.6 (8), p.1371-1389
Ort / Verlag
Weinheim: WILEY-VCH Verlag
Erscheinungsjahr
2011
Quelle
Wiley Online Library - AutoHoldings Journals
Beschreibungen/Notizen
  • A hit optimization protocol applied to the first nonnucleoside inhibitor of the ATPase activity of human DEAD‐box RNA helicase DDX3 led to the design and synthesis of second‐generation rhodanine derivatives with better inhibitory activity toward cellular DDX3 and HIV‐1 replication. Additional DDX3 inhibitors were identified among triazine compounds. Biological data were rationalized in terms of structure–activity relationships and docking simulations. Antiviral activity and cytotoxicity of selected DDX3 inhibitors are reported and discussed. A thorough analysis confirmed human DDX3 as a valid anti‐HIV target. The compounds described herein represent a significant advance in the pursuit of novel drugs that target HIV‐1 host cofactors. Targeting DEAD‐box helicase: We report the rational design of second‐generation DDX3 inhibitors endowed with nanomolar antienzymatic activity in vitro and low‐micromolar anti‐HIV activity in infected cells. We also conducted a thorough analysis to confirm DDX3 as a valid anti‐HIV target. The compounds described herein represent a significant advance in the quest for new drugs that target HIV‐1 host cofactors.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX